UPC_APP_24411/2025

System for ambulatory drug infusion comprising a filling apparatus for flexible containers

Prozessuale & UnteranträgeVergleichshomologationCourt of AppealApplication Rop 365—Vergleich erfolgt: Nach Berufung

Übersicht Entscheidungen Zitate Dokumente Zeitverlauf

Parteien

Kläger

Tandem Diabetes Care Europe B.V.
Tandem Diabetes Care, Inc.

Vertreter: Christian Dekoninck (Taylor Wessing); null (AOMB)

Beklagte

Roche Diabetes Care GmbH(Roche Group)

Vertreter: Christof Augenstein (Kather Augenstein); null (Grünecker Patent- und Rechtsanwälte)

Richter

Rian KaldenPresiding judge and legally qualified judge
Ingeborg SimonssonLegally qualified judge and judge-rapporteur
Patricia RombachLegally qualified judge
Jeroen MeewisseTechnically qualified judge
Stefan WilhelmTechnically qualified judge

Patente

EP2196231

CPC-Codes: A61M2209/045, A61M5/148, A61M5/14244

Sektor: Pharmaceutical & Medical

Ausgang

Vergleich

Eingereicht: —

Erste Entscheidung: 5. Juni 2025

Sprache: —

Vergleich erfolgt: Nach Berufung — settled commercially

The Court of Appeal confirmed a settlement agreement between Tandem Diabetes and Roche Diabetes, terminating the appeal proceedings. The settlement arose after the Central Division Paris had dismissed the revocation action and maintained EP 2 196 231 as granted.